Evidence map›Paper›PMID 25053418›Full record

ArticleThe Journal of biological chemistry2014

Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp.

Santi M Mandal, Denial Mahata, Ludovico Migliolo, Aditya Parekh, Partha S Addy, Mahitosh Mandal, Amit Basak

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microorganisms · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Axenic Long-Term Cultivation ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Review
  15. Fructose Induces Fluconazole Resistance inInternational journal of molecular sciences · 2021
    Article
  16. Challenges in Antifungal Therapy in Diabetes Mellitus.Journal of clinical medicine · 2020
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Santi M MandalFrom the Department of Chemistry, Central Research Facility, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India, the Department of Microbiology, Vidyasagar University, Midnapore 721102, West Bengal, India mandalsm@gmail.com.
Denial MahataFrom the Department of Chemistry, Central Research Facility, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Ludovico Migliolothe Programa de Pós-Graduação em Biotecnologia, Centro de Pesquisas Bioquímicas e Biofísicas, Universidade Católica Dom Bosco, Campo Grande 79117-900, Brazil, and.
Aditya ParekhFrom the Department of Chemistry, Central Research Facility, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Partha S AddyFrom the Department of Chemistry, Central Research Facility, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Mahitosh MandalFrom the Department of Chemistry, Central Research Facility, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Amit BasakFrom the Department of Chemistry, Central Research Facility, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India, absk@chem.iitkgp.ernet.in.
Indian Institute of Technology Kharagpur · INUniversidade Católica Dom Bosco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effects of glucose on the susceptibility of antifungal agents were investigated against Candida spp. Increasing the concentration of glucose decreased the activity of antifungal agents; voriconazole was the most affected drugs followed by amphotericin B. No significant change has been observed for anidulafungin. Biophysical interactions between antifungal agents with glucose molecules were investigated using isothermal titration calorimetry, Fourier transform infrared, and (1)H NMR. Glucose has a higher affinity to bind with voriconazole by hydrogen bonding and decrease the susceptibility of antifungal agents during chemotherapy. In addition to confirming the results observed in vitro, theoretical docking studies demonstrated that voriconazole presented three important hydrogen bonds and amphotericin B presented two hydrogen bonds that stabilized the glucose. In vivo results also suggest that the physiologically relevant higher glucose level in the bloodstream of diabetes mellitus mice might interact with the available selective agents during antifungal therapy, thus decreasing glucose activity by complex formation. Thus, proper selection of drugs for diabetes mellitus patients is important to control infectious diseases.

Indexed as

AnimalsAntifungal AgentsBiophysical PhenomenaCalorimetryCandidaDrug Resistance, FungalGlucoseHumansHydrogen BondingMagnetic Resonance SpectroscopyMiceSpectroscopy, Fourier Transform InfraredAntifungal AgentsGlucoseAntibiotic ResistanceCandida albicansDiabetesDrug ActionGlucose

Identifiers

PMID25053418
PMCPMC4162151
OpenAlexW2026049305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.